STOCK TITAN

Exact Sciences schedules fourth quarter 2020 earnings call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Exact Sciences Corp. (Nasdaq: EXAS) is set to release its fourth quarter 2020 financial results on February 16, 2021, after U.S. market close. Management will host a webcast and conference call at 5 p.m. EST to discuss the financial results and business progress. The company is a leading provider of cancer screening and diagnostic tests, with an emphasis on improving patient care through products like Cologuard and Oncotype DX. For further details, visit their official website.

Positive
  • Scheduled release of fourth quarter 2020 financial results indicating transparency.
  • Management intends to discuss business progress, suggesting ongoing developments.
Negative
  • None.

MADISON, Wis., Feb. 1, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its fourth quarter 2020 financial results after the close of the U.S. financial markets on February 16, 2021. Following the release, company management will host a webcast and conference call at 5 p.m. EST to discuss financial results and business progress.

Fourth quarter 2020 webcast & conference call details

    Date:

Tuesday, February 16, 2021

    Time:

5 p.m. EST, 4 p.m. CST

    Webcast:

The live webcast can be accessed at www.exactsciences.com

    Telephone:

Domestic callers, dial 833-235-7650 


International callers, dial +1 647-689-4171


Access code for both domestic and international callers: 2892148

An archive of the webcast will be available at www.exactsciences.com. A replay of the conference call will be available by calling 800-585-8367 domestically or 416-621-4642 internationally. The access code for the replay of the call is 2892148. The webcast, conference call and replay are open to all interested parties.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/exact-sciences-schedules-fourth-quarter-2020-earnings-call-301218577.html

SOURCE EXACT SCIENCES CORP

FAQ

When will Exact Sciences release its fourth quarter 2020 financial results?

Exact Sciences will release its fourth quarter 2020 financial results on February 16, 2021.

What time is the Exact Sciences fourth quarter earnings call?

The earnings call will take place at 5 p.m. EST on February 16, 2021.

Where can I listen to the Exact Sciences 2020 fourth quarter webcast?

The webcast can be accessed on Exact Sciences' official website.

What is Exact Sciences focused on?

Exact Sciences focuses on cancer screening and diagnostic tests, including products like Cologuard and Oncotype DX.

Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

EXAS Latest News

EXAS Stock Data

10.65B
182.35M
1.01%
101.55%
6.39%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
MADISON